SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical : Dyadic

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Paul Lee7/16/2012 9:53:41 AM
   of 9
 
DYADIC DEMONSTRATES INDUSTRY-LEADING BIOFUELS ENZYME PERFORMANCE



AlternaFuel® CMAX3™ performance equals and surpasses leading biofuels enzymes



JUPITER, Fla., July 16, 2012 - Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and others proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, today unveiled its latest biofuels enzyme advancement, AlternaFuel® CMAX3™. This next generation product enables the production of cellulosic biofuels and bio-based chemicals from a wide range of renewable non-food feedstocks under broad operating conditions.



Dyadic’s President and CEO, Mark Emalfarb, stated “The data supporting this product clearly demonstrates Dyadic’s scientific capabilities to leverage our C1 technology platform to create enzyme mixtures whose performance rivals the leading biofuels enzyme product on the market. This is largely due to the inherent robustness and versatility of the C1 genome and expression system, both of which have considerable untapped potential. The results obtained with AlternaFuel® CMAX3™ are not only relevant for the production of biofuels but also for bio-based chemicals and biogas. Dyadic and its licensees are continuing to develop better performing enzymes to further reduce the total cost of producing advanced biofuels and other bio-based products.”



Jan Wery, Science Director at Dyadic Netherlands, added, “AlternaFuel® CMAX3™ achieved a similar saccharification yield at pH 5.0 and substantially better results at pH 6.0 than those achieved by the current leading competitive biofuels enzyme product. Saccharification yield is defined as the relative amount of fermentable sugars released through enzymatic hydrolysis from lignocellulosic biomass such as agricultural feedstock and waste. This important parameter demonstrates the level of progress being made across the entire industrial enzyme industry in developing enzymes necessary for lignocellulosic biomass to replace petroleum in fuel and chemical production.”



About AlternaFuel® CMAX3™



AlternaFuel® CMAX3™is the latest generation of a cellulase and hemicellulase complex based on Dyadic’s C1 platform technology which enables efficient conversion of multiple forms of non-food biomass into fermentable sugars at broad pH and temperature ranges that can be used to produce biofuels, bio-based chemicals, biogas and other bio-based products.



For more information on AlternaFuel® CMAX3™, please visit Dyadic’s recently remodeled website at www.dyadic.com.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext